MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025 GlobeNewswire October 30, 2025 ST. LOUIS, Oct. 30, 2025 (GLOBE NEWSWIRE) — MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company's transdermal GFR technology has […]

PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — 23andMe Research Institute, a nonprofit medical research organization, today announced the formation of its Privacy Advisory Board. Composed of leading experts in health data privacy, data ethics, and consumer advocacy, the Board will provide strategic guidance on the protection of member information and the organization's responsible

New Clinical and Translational Data on PDS Biotechnology's Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire October 30, 2025 Three abstracts accepted for presentation, including one rapid oral abstract session Presentations to highlight ongoing clinical and translational research across PDS Biotechnology's

Toronto, Oct. 30, 2025 (GLOBE NEWSWIRE) — This Diabetes Awareness Month, Diabetes Canada is launching a new campaign to confront the stigma faced by more than four million people diagnosed with diabetes in Canada. The campaign challenges harmful myths and misinformation that lead to blame, shame, and judgment–deeply affecting the well-being of people managing this

Toronto, ON, Oct. 30, 2025 (GLOBE NEWSWIRE) — On October 27, TECHNATION hosted the 2025 TECH7 Summit in Ottawa, convening over 200 senior government officials, global tech leaders, and policy experts to address the most pressing challenges facing our digital economy, from AI adoption and cybersecurity to trade and digital infrastructure. TECH7 is a coalition

Veru Announces Pricing of $25 Million Public Offering GlobeNewswire October 30, 2025 MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, announced today the pricing of an underwritten public offering of (i) 1,400,000

(NYSE:ABM),(NYSE:IRM), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, today announced the appointment of Barry Hytinen to its Board of Directors. Mr. Hytinen currently serves as Executive Vice President and Chief Financial Officer of Iron Mountain Incorporated (NYSE: IRM), a global leader in

BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial GlobeNewswire October 30, 2025 SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first

(NASDAQ:EDBL),(NASDAQ:EDBLW), BELVIDERE, NJ, Oct. 30, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the New Jersey Economic Development Authority (NJEDA) has preliminarily approved the Company's application under the Technology

XWELL Expands Priority Pass Partnership to Bring Wellness Worldwide Priority Pass members can now enjoy XWELL's exclusive wellness experiences at select international airport spas GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go,